Hospital News
Return to Lung Cancer Screening Overview
More on Lung Cancer Screening
- New Clinical Trial for Patients With Asbestos-Associated Lung Cancer
- NewYork-Presbyterian/Weill Cornell Physician-Scientists Present Latest Cancer Findings at American Society of Clinical Oncology (ASCO) Meeting
- Lung Cancer Screening Regimen Provides Opportunity for Cure
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Landmark Study Reveals Lung Cancer 10-Year Survival Dramatically Improves With Annual CT Screening and Prompt Treatment
- Female Smokers Face Double the Risk for Lung Cancer Compared to Male Smokers, NewYork-Presbyterian/Weill Cornell Study Finds
- Smokers and Former Smokers Should Be Screened for Lung Cancer, Even if They Do not Have Symptoms
- COX-2 Inhibitor May Boost Cancer Treatment, NewYork Weill Cornell Study Shows
- Lung Cancer CT Screening Is Cost-Effective, Weill Cornell Study Shows
- New York Weill Cornell Researchers Report CT Screening of Patients at Risk for Lung Cancer Saves Lives
- Tumor Size Predicts Survival in Most Common Type of Lung Cancer
- New York Weill Cornell To Lead Statewide Consortium in Early CT Screening for Lung Cancer
- Annual CT Screening for Lung Cancer Is Cost-Effective for High-Risk Persons, Study Finds
- New Book by NewYork Weill Cornell Radiologist Offers Hope to Those Who May Face Lung Cancer
- NewYork-Presbyterian Hospital's Weill Cornell Medical Center Announces Preliminary Lung Cancer Data Involving Patients Treated With Arthritis Medication
- Female Smokers Twice as Likely as Men To Develop Lung Cancer, Weill Cornell Study Finds
- New Research To Address Pressing Question: Will Early Lung Cancer Detection Lead to Tobacco Cessation?
Lung Cancer Screening
The best hope for curing lung cancer is finding it early.
Now physicians in the Lung Screening Program at NewYork-Presbyterian Hospital/Weill Cornell Medical Center are conducting two important research studies related to the early detection of lung cancer.
Both projects offer study participants a free lung screening using CT scans. We are looking for smokers and people who have never smoked for these trials. If you meet the requirements listed below for one of these studies, you may be eligible to participate.
Study I
- Are you 40 years of age or older; and
- have never smoked; and
- have a history of secondhand smoke exposure?
Study II
- Are you 50 years of age or older; and
- a current smoker?
Study participants may also have access to additional tests and to materials to help them quit smoking.
Physician researchers at NewYork-Presbyterian/Weill Cornell have shown that low-dose Computed Tomographic (CT) screening may detect lung cancer in its earliest and most treatable stages.
Lung cancer remains the leading cause of cancer death in both men and women. The estimated cure rate for lung cancer in the absence of early detection is between five and ten percent, but may increase to 92 percent when the cancer is diagnosed and treated at its earliest stage. CT scans can detect tiny spots on the lungs, called nodules, years before they might ever be seen on regular X-rays. This 20-second, non-invasive test uses low-dose X-rays to provide a cross sectional view of body tissues and organs which can help physicians detect cancer sooner.
Learn more about lung cancer screening on the International Early Lung Cancer Action Program website.
For more information about the NewYork-Presbyterian/Weill Cornell Lung Screening Program, or to find out if you are eligible to participate, please call 212-746-2116 or email lungstudies@ielcap.org.
